On May 15th, according to Richard Yu, the CEO of the Consumer BG at Huawei, “Huawei WATCH 4 series will be the first to support high blood sugar risk assessment research.” The Huawei WATCH 4 series will debut at Huawei’s new product launch event on May 18th.
According to the poster, this product is not a medical device. The measurement data and results are for reference only and should not be used as a basis for diagnosis or treatment.
This function requires users to participate in blood sugar health research initiated by third-party professional medical institutions, and is not suitable for users under 18 years of age, type I diabetes patients, gestational diabetes patients, and other special types of diabetes patients.
For example, for pictures, high blood sugar risk assessment can assess the types within a week, such as medium risk. “There may be short-term blood sugar fluctuations and excessive intake of high-sugar, high-oil and high-fat diets may increase the risk of high blood sugar. Users can also click the button to start a new round of evaluation.”
The flagship smartwatch of Huawei WATCH 4 series has been unveiled at the European launch event. The Huawei WATCH 4 Pro features a 48mm titanium case, a 1.5-inch LTPO AMOLED display covered with sapphire glass and weighs only 48 grams. In comparison, the Huawei WATCH 4 is slightly smaller with a 46mm stainless steel case.